| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655632 | Digestive and Liver Disease | 2017 | 5 Pages |
Abstract
Our study suggests that an exclusive neoadjuvant approach when associated with a D2 lymph node dissection in resectable gastric and gastro-esophageal junction adenocarcinoma appears a feasible strategy with encouraging survival.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Eugenio Fernandez, Wulfran Cacheux, Jean-Louis Frossard, Thibaud Koessler, Magali Abou, Michael Moniez, Olivier Huber, Giacomo Puppa, Arnaud Roth,